Weekly Recap | Moderna -4.46%, Citi cuts to SellWeekly Review·Oct 3, 2026 at 07:17 AMMRNA+4.81%MRNY+3.90%
Weekly Recap | Moderna +29.11%, closing in on record highsWeekly Review·Sep 26, 2026 at 06:45 AMMRNA+4.81%MRNY+3.90%
Weekly Recap | Moderna +6.99%, cancer vaccine in focusWeekly Review·Sep 19, 2026 at 06:27 AMMRNA+4.81%MRNY+3.90%
Weekly Recap | Moderna -1.09%, tumour vaccine milestoneWeekly Review·Sep 12, 2026 at 06:22 AMMRNA+4.81%MRNY+3.90%
Weekly Recap | Moderna +5.48%, consensus target below spotWeekly Review·Sep 5, 2026 at 07:36 AMMRNA+4.81%MRNY+3.90%
Weekly Recap | Moderna -4.92%, convertible offering weighsWeekly Review·Aug 29, 2026 at 06:02 AMMRNA+4.81%MRNY+3.90%